Anxiety and Cardiovascular Autonomic Control
NCT00005471 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-03-16
Summary
To evaluate the hypothesis that chronic anxiety and/or anxiety disorders resulted in hyperkinetic cardiovascular autonomic regulation, often associated with increased coronary risk.
Conditions
- Cardiovascular Diseases
- Heart Diseases
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
David Sparrow · Brigham and Women's Hospital
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-09-30
- Completion
- 2001-01-31
More Related Trials
-
Opioid Compromise in Hypertension--Modulating Factors
NCT00005434 ·Status: COMPLETED
-
Hypnosis in Autonomic Function
NCT00061009 ·Status: COMPLETED
-
Exercise and Pharmacotherapy for Anxiety in Cardiac Patients
NCT02516332 ·Status: COMPLETED ·Phase: NA
-
Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
NCT04826497 ·Status: UNKNOWN ·Phase: PHASE4
-
24 Hour Ambulatory Cardiac Oxygen Consumption
NCT05170061 ·Status: COMPLETED ·Phase: PHASE3
-
2019-nCoV Outbreak and Cardiovascular Diseases
NCT04255940 ·Status: UNKNOWN
-
Arrhythmias, Microalbuminuria and Corticosteroids
NCT03453931 ·Status: COMPLETED
-
Analysis of Atropine and Propranolol Induced Changes
NCT00251602 ·Status: COMPLETED ·Phase: PHASE1
-
Dynamic Cardio-vascular, Cerebro-vascular and Cortical Interaction in Healthy Adult Subjects
NCT06785181 ·Status: RECRUITING ·Phase: NA
-
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
NCT01798992 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Cardiac Sympathetic Blockade in Patients With Chronic Heart Failure
NCT02282618 ·Status: UNKNOWN
-
Dysautonomia in Patients Post COVID-19 Infection
NCT04716465 ·Status: UNKNOWN
-
Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury
NCT05399576 ·Status: UNKNOWN ·Phase: PHASE2
-
The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation
NCT02315313 ·Status: UNKNOWN
-
Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System
NCT03109795 ·Status: TERMINATED ·Phase: PHASE4
-
Safety Study of Pyridostigmine in Heart Failure
NCT01415921 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
NCT02560805 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Autonomic Function on Coronary Vasomotion
NCT01877993 ·Status: COMPLETED
-
Exercise Improve Sympathetic Modulation in Chronic Heart Failure Patients
NCT02219451 ·Status: COMPLETED ·Phase: PHASE4
-
The Nitrite and Coronary Flow Study
NCT04354051 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Predictive Value of the Heart Rate Response to Breathing Maneuvers for Inducible Myocardial Perfusion Deficits
NCT05516615 ·Status: COMPLETED
-
Targeting Sympathetic Overactivity in Heart Failure Patients With Statins
NCT01097785 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular and Cerebrovascular Control in Healthy Subjects
NCT05706532 ·Status: RECRUITING
-
Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China
NCT03116854 ·Status: COMPLETED
-
Intravenous Beta-blockade for Improvement of Autonomic Activity
NCT00700466 ·Status: COMPLETED